Literature DB >> 20811826

Cancer genetics: risks and mechanisms of cancer in women with inherited susceptibility to epithelial ovarian cancer.

Lee P Shulman1, Jeffrey S Dungan.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20811826      PMCID： PMC3086477          DOI： 10.1007/978-1-4419-6518-9_6

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  31 in total

1.  Familial endometrial cancer in female carriers of MSH6 germline mutations.

Authors:  J Wijnen; W de Leeuw; H Vasen; H van der Klift; P Møller; A Stormorken; H Meijers-Heijboer; D Lindhout; F Menko; S Vossen; G Möslein; C Tops; A Bröcker-Vriends; Y Wu; R Hofstra; R Sijmons; C Cornelisse; H Morreau; R Fodde
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

2.  Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.

Authors:  V McGuire; A Felberg; M Mills; K L Ostrow; R DiCioccio; E M John; D W West; A S Whittemore
Journal:  Am J Epidemiol       Date:  2004-10-01       Impact factor: 4.897

3.  Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer.

Authors:  A S Whittemore; G Gong; J Itnyre
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

4.  A prospective study of reproductive factors and risk of epithelial ovarian cancer.

Authors:  S E Hankinson; G A Colditz; D J Hunter; W C Willett; M J Stampfer; B Rosner; C H Hennekens; F E Speizer
Journal:  Cancer       Date:  1995-07-15       Impact factor: 6.860

5.  Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.

Authors:  K Cederquist; M Emanuelsson; F Wiklund; I Golovleva; R Palmqvist; H Grönberg
Journal:  Clin Genet       Date:  2005-12       Impact factor: 4.438

Review 6.  Familial ovarian cancer and early ovarian cancer: biologic, pathologic, and clinical features.

Authors:  B A Werness; G H Eltabbakh
Journal:  Int J Gynecol Pathol       Date:  2001-01       Impact factor: 2.762

7.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

8.  Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

Authors:  Tom Walsh; Silvia Casadei; Kathryn Hale Coats; Elizabeth Swisher; Sunday M Stray; Jake Higgins; Kevin C Roach; Jessica Mandell; Ming K Lee; Sona Ciernikova; Lenka Foretova; Pavel Soucek; Mary-Claire King
Journal:  JAMA       Date:  2006-03-22       Impact factor: 56.272

9.  A systematic review and meta-analysis of family history and risk of ovarian cancer.

Authors:  J F Stratton; P Pharoah; S K Smith; D Easton; B A Ponder
Journal:  Br J Obstet Gynaecol       Date:  1998-05

10.  Cancer incidence in the first-degree relatives of ovarian cancer patients.

Authors:  A Auranen; E Pukkala; J Mäkinen; R Sankila; S Grénman; T Salmi
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640
View more
  2 in total

Review 1.  Pancreatic cancer actionable genes in precision medicine and personalized surgery.

Authors:  Juehua Yu; Shi-He Liu; Robbi Sanchez; John Nemunaitis; Enrique Rozengurt; F Charles Brunicardi
Journal:  Surgeon       Date:  2016-06-28       Impact factor: 2.392

Review 2.  A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review).

Authors:  Luca Falzone; Giuseppa Scandurra; Valentina Lombardo; Giuseppe Gattuso; Alessandro Lavoro; Andrea Benedetto Distefano; Giuseppe Scibilia; Paolo Scollo
Journal:  Int J Oncol       Date:  2021-06-16       Impact factor: 5.650
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.